A recent study from the Harvard-affiliated Dana-Farber Cancer Institute suggests that those who consume caffeinated coffee regularly may have a reduced risk for colon cancer recurrence. The study included 1,000 individuals with stage 3 colon cancer, and tracked the dietary habits of these people during chemotherapy treatment and again 6 months after treatment. It was found that individuals who drank 4 or more cups of coffee per day were 42% less likely to have cancer return than non-coffee drinkers, and 34% less likely to die of cancer.
Dr. Charles Fuch, the senior author of the paper, is encouraged by the results and the positive health implications coffee can have. “Regular coffee intake has been associated with a reduced risk of type 2 diabetes, and it may be that through a similar mechanism, coffee may also improve outcomes for people with advanced colon cancer,” says Dr. Fuch.
This study was published in The Journal of Clinical Oncology on August 17, 2015.
SRC: Read the complete article here: www.health.harvard.edu/colorectal-cancer/harvard-researchers-link-coffee-with-reduced-colon-cancer-recurrence